Generess Fe is a type of oral contraceptive that comes as a chewable tablet. It works to prevent pregnancy by stopping ovulation, altering the cervical mucus, and changing the lining of the uterus. The standard dosage is to take one tablet once a day, at the same time every day. Possible side effects include headaches, nausea, and vomiting.
What Is Generess Fe?
Generess™ Fe (norethindrone/ethinyl estradiol) is a prescription oral contraceptive, commonly known as a birth control pill. It comes as a chewable pill, which is particularly useful for women who have difficulty swallowing tablets.
Generess Fe is made by Warner Chilcott Company, Inc., for Watson Pharma, Inc.
How Does Generess Fe Work?
Generess Fe is a combined oral contraceptive, which means that it is a birth control pill that contains two different types of hormones. It contains both an estrogen (ethinyl estradiol) and a progestin (norethindrone). The hormones in Generess Fe prevent pregnancy primarily by stopping ovulation (the maturation and release of eggs from the ovaries).
Generess Fe also works to prevent pregnancy in two other, minor ways. It changes the cervical mucus (the fluid of the cervix, which is the lower, narrow part of the uterus that is connected to the vagina), making it more difficult for sperm to enter the uterus. It also alters the lining of the uterus (called the endometrium), making it less receptive to an embryo.
The first 24 tablets in each pack of Generess Fe contain the active hormones. The last 4 tablets do not contain any hormones, but they do contain iron. The chemical symbol for iron is Fe. This iron may help replace the iron you lose when you have your period, which may help prevent anemia.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Generess Fe [package insert]. Morristown, NJ: Watson Pharma, Inc.;2011 January.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed July 14, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click